Parliamentary panel tells Centre to promote cheaper, domestically produced COVID-19 medicines
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment.
New Delhi: A Parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19 , and check recommendation and cap prices of expensive medicines pushed by pharma companies, sources said.
During a meeting of Parliamentary Standing Committee on Home Affairs, members also demanded that the maximum price of COVID-19 medicines be capped, they said.
Home Secretary Ajay Bhalla, Joint Secretary in Health Ministry Lav Agarwal and other officials were present in the meeting of the standing committee on home affairs chaired by Congress leader Anand Sharma.
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment, sources in the panel said.
The committee members expressed concern over black marketing of medicines.
Naming three cheaper and easily available medicines, the committee members questioned why are they not being promoted despite they being equally effective.
Parliament's Monsoon Session: Day 2 sees Oppn disrupt LS over Pegasus row, target Centre in RS on COVID
Union Health Minister Mansukh Mandaviya in Rajya Sabha said that if there is any underreporting of COVID-19 deaths, it is by the states and not the Union government
Parliament Monsoon Session 2021 LIVE updates on day 2: Wrapping up his reply in the Rajya Sabha, health minister Mansukh Mandaviya said the Centre is planning to to set up 1,573 oxygen plants of which 316 have already been commissioned
Scheduled commercial banks (SCBs) were carrying NPAs worth Rs 8.96 lakh crore on their balance sheet at the end of March 2020